163 related articles for article (PubMed ID: 38421191)
1. Identification of fungal natural products with potent inhibition in
Jiang T; Godinez-Macias KP; Collins JE; Lee JW; Wendt KL; Carolino K; Chakrabarti D; Cichewicz RH; Winzeler EA
Microbiol Spectr; 2024 Apr; 12(4):e0414223. PubMed ID: 38421191
[TBL] [Abstract][Full Text] [Related]
2. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS
ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728
[TBL] [Abstract][Full Text] [Related]
3. Targeted Phenotypic Screening in
Subramanian G; Belekar MA; Shukla A; Tong JX; Sinha A; Chu TTT; Kulkarni AS; Preiser PR; Reddy DS; Tan KSW; Shanmugam D; Chandramohanadas R
mSphere; 2018; 3(1):. PubMed ID: 29359192
[TBL] [Abstract][Full Text] [Related]
4. Novel Toxoplasma gondii inhibitor chemotypes.
Sanford AG; Schulze TT; Potluri LP; Hemsley RM; Larson JJ; Judge AK; Zach SJ; Wang X; Charman SA; Vennerstrom JL; Davis PH
Parasitol Int; 2018 Apr; 67(2):107-111. PubMed ID: 29081387
[TBL] [Abstract][Full Text] [Related]
5. Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box.
Spalenka J; Escotte-Binet S; Bakiri A; Hubert J; Renault JH; Velard F; Duchateau S; Aubert D; Huguenin A; Villena I
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133550
[No Abstract] [Full Text] [Related]
6. Characterization of Plasmodium Atg3-Atg8 Interaction Inhibitors Identifies Novel Alternative Mechanisms of Action in Toxoplasma gondii.
Varberg JM; LaFavers KA; Arrizabalaga G; Sullivan WJ
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158278
[TBL] [Abstract][Full Text] [Related]
7. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.
Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F
Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321
[TBL] [Abstract][Full Text] [Related]
8. Repurposing the Medicines for Malaria Venture's COVID Box to discover potent inhibitors of Toxoplasma gondii, and in vivo efficacy evaluation of almitrine bismesylate (MMV1804175) in chronically infected mice.
Dos Santos BR; Ramos ABDSB; de Menezes RPB; Scotti MT; Colombo FA; Marques MJ; Reimão JQ
PLoS One; 2023; 18(7):e0288335. PubMed ID: 37418497
[TBL] [Abstract][Full Text] [Related]
9. Rapid discovery of inhibitors of Toxoplasma gondii using hybrid structure-based computational approach.
Kortagere S; Mui E; McLeod R; Welsh WJ
J Comput Aided Mol Des; 2011 May; 25(5):403-11. PubMed ID: 21359560
[TBL] [Abstract][Full Text] [Related]
10. Repurposing the open access malaria box to discover potent inhibitors of Toxoplasma gondii and Entamoeba histolytica.
Boyom FF; Fokou PV; Tchokouaha LR; Spangenberg T; Mfopa AN; Kouipou RM; Mbouna CJ; Donfack VF; Zollo PH
Antimicrob Agents Chemother; 2014 Oct; 58(10):5848-54. PubMed ID: 25049259
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiparasitic and antitumor activity of 2, 4-diamino-6-(arylmethyl)-5,6,7,8-tetrahydroquinazoline analogues of piritrexim.
Rosowsky A; Papoulis AT; Forsch RA; Queener SF
J Med Chem; 1999 Mar; 42(6):1007-17. PubMed ID: 10090784
[TBL] [Abstract][Full Text] [Related]
12. Analogs of Marinopyrrole A Show Enhancement to Observed
Martens MC; Liu Y; Sanford AG; Wallick AI; Warner RC; Li R; Davis PH
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0079421. PubMed ID: 34662196
[TBL] [Abstract][Full Text] [Related]
13. Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycle.
D'Angelo JG; Bordón C; Posner GH; Yolken R; Jones-Brando L
J Antimicrob Chemother; 2009 Jan; 63(1):146-50. PubMed ID: 18988681
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of new 4-thiazolidinones on invasion and growth of Toxoplasma gondii.
Molina DA; Ramos GA; Zamora-Vélez A; Gallego-López GM; Rocha-Roa C; Gómez-Marin JE; Cortes E
Int J Parasitol Drugs Drug Resist; 2021 Aug; 16():129-139. PubMed ID: 34102589
[TBL] [Abstract][Full Text] [Related]
15. Identification of potential dual -targets anti- toxoplasma gondii compounds through structure-based virtual screening and in-vitro studies.
Salin NH; Noordin R; Al-Najjar BO; Kamarulzaman EE; Yunus MH; Karim IZA; Nasim NNM; Zakaria II; Wahab HA
PLoS One; 2020; 15(5):e0225232. PubMed ID: 32442170
[TBL] [Abstract][Full Text] [Related]
16. Human toxoplasmosis-Searching for novel chemotherapeutics.
Antczak M; Dzitko K; Długońska H
Biomed Pharmacother; 2016 Aug; 82():677-84. PubMed ID: 27470411
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of
Węglińska L; Bekier A; Trotsko N; Kaproń B; Plech T; Dzitko K; Paneth A
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2621-2634. PubMed ID: 36165032
[TBL] [Abstract][Full Text] [Related]
18. Modification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii.
Stec J; Fomovska A; Afanador GA; Muench SP; Zhou Y; Lai BS; El Bissati K; Hickman MR; Lee PJ; Leed SE; Auschwitz JM; Sommervile C; Woods S; Roberts CW; Rice D; Prigge ST; McLeod R; Kozikowski AP
ChemMedChem; 2013 Jul; 8(7):1138-60. PubMed ID: 23776166
[TBL] [Abstract][Full Text] [Related]
19. Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo.
Mui EJ; Schiehser GA; Milhous WK; Hsu H; Roberts CW; Kirisits M; Muench S; Rice D; Dubey JP; Fowble JW; Rathod PK; Queener SF; Liu SR; Jacobus DP; McLeod R
PLoS Negl Trop Dis; 2008 Mar; 2(3):e190. PubMed ID: 18320016
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of antiretroviral compounds against Toxoplasma gondii in vitro.
Wang JL; Elsheikha HM; Li TT; He JJ; Bai MJ; Liang QL; Zhu XQ; Cong W
Int J Antimicrob Agents; 2019 Dec; 54(6):814-819. PubMed ID: 31479744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
